Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · Seattle Cancer Care Alliance · +42 more institutions
Abstract
The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy. The NCCN Management of Immunotherapy-Related Toxicities Panel is an interdisciplinary group of representatives from NCCN Member Institutions, consisting of medical and hematologic oncologists with expertise across a wide range of disease sites, and experts from the areas of dermatology, gastroenterology, endocrinology, neurooncology, nephrology, cardio-oncology, ophthalmology, pulmonary medicine, and oncology nursing. The content featured in this issue is an excerpt of the recommendations for managing toxicities related…
Citation impact
- FWCI
- 38.90
- Percentile
- 100%
- References
- 116
Authors
36- JAJohn A. ThompsonCorresponding
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Seattle Cancer Care Alliance, Fred Hutch Cancer Center, Cancer Research Center
- BJBryan J. Schneider
University of Michigan
- JRJulie R. Brahmer
Sidney Kimmel Comprehensive Cancer Center
- AAAmaka Achufusi
University of Wisconsin Carbone Cancer Center
- PAPhilippe Armand
Dana-Farber Brigham Cancer Center
Topics & keywords
- Medicine
- Immunotherapy
- Internal medicine
- Oncology
- Cancer
- Clinical Oncology
- Intensive care medicine
- Good health and well-being